Investor
Abingworth
London · United Kingdom
A transatlantic life science investment firm focused on turning breakthrough science into new medical treatments.
Stage
Seed
Sectors
Not confirmed
Cheque
Not confirmed
Invests in
3 countries
Invests in
About
This firm focuses on life science investing to turn breakthrough science into breakthrough medicine. It supports biopharma companies on both sides of the Atlantic to convert scientific discoveries into new treatments for patients. The team invests in private and public companies across seed, early, and development stages. They seek game-changers and paradigm-shifts that materially improve patients' lives. With offices in London, New York, and San Francisco, the firm provides capital and experience to its portfolio.
How to approach
Submit a proposal via the website contact page including non-confidential information about the company approach and its advantages.
Portfolio · 1 · tap a company to read about it